Background. Association between body mass index (BMI) and long-term mortality is poorly studied in older hospitalized populations.
T HE association between obesity and cardiovascular and all-cause mortality is well established. However, there is still uncertainty about the effect of age and comorbidities on this association. Large collaborative studies using the body mass index (BMI) to define obesity have shown that the mortality risk associated with obesity markedly declines with age (1, 2) . Studies in older populations have shown a paradoxical, inverse association between the BMI and survival (3) (4) (5) . This inverse association was essentially accounted for by high mortality in patients with a low BMI (<20.0 kg/m 2 ), but there was no evidence of excess mortality in obese patients, commonly defined by a BMI higher than 30.0 kg/m 2 (3) . Similarly, an "obesity paradox" has been reported in younger patients with chronic renal insufficiency, heart failure, or coronary heart disease (6, 7) . The underlying mechanisms remain incompletely understood. One possibility is that comorbidities and/ or malnutrition are associated with both mortality and unintentional weight loss, thereby confusing the association between the BMI and mortality (8, 9) . Another possibility is that a high BMI is a protective factor against mortality from acute diseases or comorbidities, as a higher fat or lean body mass may somehow offer a greater metabolic or nutritional reserve (6) .
Older patients in medical or geriatric care represent a population with a particularly high prevalence of comorbidities and functional disabilities. The researchers have previously observed in two prospective studies that the BMI is strongly associated with survival in such patients (10) (11) (12) . One of these studies was initially conducted to determine the impact of cognitive disorders on adverse outcomes of hospitalization and mortality, relative to other risk factors and comorbidities; an extensive baseline characterization of comorbidities and long-term mortality data are therefore both available (13, 14) . In the present report, the researchers used the data from this cohort to determine the relative impact of the BMI, comorbidities, and related factors on 4-year all-cause mortality after a hospital admission.
Patients and Methods
The study was conducted in a 294-acute bed geriatric hospital where 22.7% patients were directly admitted from the community, 54.0% were referred from the emergency unit and 23.3% were transferred from other inpatient services. Patients and data collection have been described previously (13) . Briefly, a representative sample of all patients aged more than 75 years, consecutively admitted between January 2004 and December 2005 were randomly selected, with a sampling fraction of 30% using a computer algorithm. The exclusion criteria were disorders interfering with psychometric assessment and terminal illness. The local Ethics Committee approved the protocol, and patients, families, or legal representatives provided signed written informed consent. Demographic data for the patients studied did not significantly differ from those admitted during the recruitment period (13) . Data collected are listed in Table 1 .
Medical history was recorded on standardized forms; the following parameters were recorded in all patients:
1. Age, sex, marital status, living arrangements, and current smoking. 2. The BMI (kg/m 2 ) was calculated from measured weight and height at admission. To avoid bias associated with acute fluid retention diseases all patients were weighted again 1 week after admission, the lowest weight was taken as the reference one. In hospital, weight was measured on a large scale located at the floor level allowing weighting of a patient while sitting on his wheel chair. Weight and height were measured by research technicians to the nearest 0.1 kg and centimeter, respectively, on patients wearing a hospital gown or light clothing before breakfast. Both measurements were performed later during hospitalization in patients initially unable to stand. Thanks to the prospective design of the study, height was measured on every follow-up visit, by the same team. 3. Comorbidities were assessed with the CIRS by extensive review of the patient's medical records for Notes: Data are shown as mean ± SD or as percentage. Bold entries = statistically significant. BMI = body mass index; MNA = Mini Nutritional Assessment; MMSE = Mini-Mental State Examination; CIRS = Cumulative Illness Rating scale-Geriatrics; CIRS-no DM = CIRS modified score, without diabetes; CRP = C-reactive protein; GFR = glomerular filtration rates. diagnoses established at or before enrolment in this study. This scale has previously been validated in the hospital, and shown to predict length of stay, institutionalization, intrahospital death, and long-term mortality (14) . The CIRS incorporates medical conditions according to 14 categories (heart disease, hypertension, hematopoietic, respiratory, eyes and ears, upper gastrointestinal, lower gastrointestinal, liver, kidneys, genitourinary, musculoskeletal, neurological, endocrine-metabolic, psychiatric-dementia), rated on a scale from 0 to 4. The total score (CIRS score) is calculated as the sum of the 14 scores. As diabetes is considered as a comorbidity in the endocrine-metabolic category, a modified score (CIRS-no DM) omitting this category was calculated. It is important to note that obesity was not included as a comorbidity item in this category, contrary to the instructions provided in the users' manual (19). 4. Arterial hypertension was defined by a physician diagnosis and/or ongoing treatment. The diabetes status was abstracted from the Charlson index, and verified by individual chart review (12) . Ischemic heart disease was defined as myocardial infarction based on previous medical history and/or ongoing treatment and was confirmed by revision of individual hospital charts. Stroke was identified by history and physical examination, and confirmed by cerebral imaging. The presence of atrial fibrillation was determined by standard ECG at admission. Congestive heart failure was abstracted from the ICED score (15) . The presence of malignancy was abstracted from the Charlson score, combining "solid tumor with metastasis," "lymphoma," and "leukemia" into a single parameter. 5. The short version of the MNA-SF was administered, considering the 2 weeks prior admission as the reference period (16, 17) . A score 12-14 indicates normal nutritional status, 8-11 "at risk of malnutrition," and 0-7 malnutrition. 6. Hemoglobin, serum albumin, C-reactive protein, and creatinine were determined by standard techniques. The GFR was calculated using both the Cockcroft-Gault formula adjusted for body surface area and the 4-parameter Modification of Diet in Renal Disease formula, as previously described (18) .
The outcome of interest was death from any cause by December 31, 2009. Information was obtained through access to the population registry of the State of Geneva.
Statistical Methods
Comparison among the four BMI categories was performed using one-way analysis of variance or the KruskalWallis nonparametric analysis of variance for continuous variables and the χ 2 test for binary variables. Survival data were analyzed using univariate and multiple Cox models taking into account the time to the event. Kaplan-Meier survival curves were compared using the log-rank test. Results are presented as mean ± SD. Stata version 12 was used for all analysis and p < .05 was considered statistically significant.
Results

Patients' Characteristics According to BMI Categories
Of the 496 randomly selected patients, 52 were excluded (20 major behavioral problems, 9 unable to communicate, 8 terminally ill, 7 lived outside the state of Geneva, 5 with no family or legal representative), and 3 with incomplete data. Overall, 444 (90%) patients had full data and were included in this study (mean age 85.3 ± 6.7 years; 74.0% women). The mean BMI was 24.1 + 4.9 kg/m 2 . Thus, 94, 79, 115, and 56 patients had a BMI less than 20, 20-24.9, 25-29.9, and greater than or equal to 30 kg/m 2 , respectively. The patients' characteristics according to BMI categories are shown in Table 1 . Patients with a higher BMI were significantly younger. They had a higher prevalence of diabetes, hypertension, and congestive heart failure, but the researchers observed no significant difference in the prevalence of other vascular comorbidities. The prevalence of chronic renal insufficiency was higher in obese patients when estimated by the 4-parameter Modification of Diet in Renal Disease formula and lower when estimated by the Cockcroft-Gault formula, likely reflecting biases introduced by age, gender, and body weight in the estimation of GFR by these formulas. The prevalence of malignancies was significantly lower in the higher BMI categories. Patients with a higher BMI had a higher global comorbidity load as judged from the CIRS score. This higher score was accounted for by the higher prevalence of diabetes, as there was no significant difference in CIRS-no DM scores, that is, after exclusion of the endocrine/ metabolic category. The differences in MNA scores across BMI categories were expected, as the BMI is a major item of this score. There were no significant differences in the gender ratio and the prevalence of smoking across BMI categories.
All-Cause Mortality According to BMI Categories
Of the 444 patients included, 23 (5.2%) had died during their hospital stay, 97 (22%) and 225 (51%) had died 1 and 4 years after discharge, respectively. Mortality according to BMI categories is shown in Figure 1 . Survival in patients with a BMI greater than or equal to 30 kg/m 2 was significantly better than in lower BMI categories (<20 kg/m 2 , 20-24.9 kg/m 2 , and 25-29.9 kg/m 2 ; p = .05 when comparing all four categories and p = .013 when comparing patients with a BMI > 30 kg/m 2 to the three lower categories combined, by the log-rank test). Importantly, there were no survival differences between patients from the three lower BMI categories. The analysis was repeated by BMI quartiles rather than by predetermined categories. Again, survival was significantly better (p = .011) in patients in the highest quartile (BMI > 27.2 kg/m 2 ), without any significant differences in survival between the three lower quartiles (<20.6, 20.6-23.4, >23.4-27.2 kg/m 2 ). In simple Cox models, 4-year all-cause mortality was inversely associated with a BMI higher than 30 kg/m 2 . It was also predicted by age, male gender, serum albumin, CIRS score, GFR, congestive heart failure, atrial fibrillation, and malignancies, but not by MNA scores, other individual comorbidities and smoking (Table 2 , model 0). In a multiple model adjusting for individual comorbidities, a BMI higher than 30 kg/m 2 remained strongly, inversely associated with mortality (model 1). The researchers next attempted to adjust for combined comorbidities and malnutrition by generating a model including CIRS scores, MNA scores, and serum albumin (model 2). A BMI higher than 30 kg/m 2 remained strongly associated with 4-year mortality, along with CIRS scores, but not with MNA scores or serum albumin. Finally when individual comorbidities, CIRS scores, MNA scores, and serum albumin and smoking were all included in the model (model 3), a BMI higher than 30 kg/m 2 remained strongly, inversely associated with 4-year mortality. To exclude a gender selection bias, the analysis was repeated in women only. In the complete multiple model (model 3 as defined earlier, restricted to women), mortality was associated with a BMI higher than 30 kg/m 2 (hazard ratio [HR] = 0.48, p = .02), as well as with age (HR = 1.05, p = .005) and CIRS scores (HR = 1.07, p = .002). Interestingly, diabetes was associated with 4-year mortality both in simple (HR = 1.50, p = .048) and in multiple models (HR = 1.58, p = .047), that is, with or without adjustment for BMI, malnutrition, and comorbidities. The Cox analysis was repeated using BMI quartiles, with very similar results. Four-year mortality was inversely associated with a BMI in the highest quartile (>27.2 kg/m 2 ; HR = 0.61, p = .016), and positively associated with age (HR = 1.05, p = .001), male gender (HR = 1.65, p = .001), and CIRS scores (HR = 1.09, p < .0001).
One-year mortality was not associated with a BMI higher than 30 kg/m 2 . However, in a complete Cox model (model 3 as defined in Table 2 ) it was associated with age (HR = 1.05, p = .017), CIRS scores (HR = 1.15, p < .0001), and serum albumin (HR = 0.96, p = .042), but with none of the individual comorbidities.
Discussion
The main finding of this study is that 4-year all-cause mortality is strongly, inversely associated with obesity defined by a BMI higher than 30 kg/m 2 , or even with a BMI higher than 27.2 kg/m 2 in older patients admitted for hospital care. This "obesity paradox" appears not to be explained by the negative impact of associated comorbidities. Indeed, the prevalence of vascular comorbidities, diabetes, and CIRS scores were comparable or even higher in obese patients. The prevalence of malignancies was inversely associated with BMI categories, but malignancies failed to account for the "protective" effect of a high BMI, likely due to their comparatively low overall prevalence. Further, the association of the BMI with survival persisted after adjustment for age, gender, comorbidities (whether assessed individually or by the CIRS score), malnutrition, and smoking, and thus could not be accounted for by these parameters. Finally, it is important to note that unlike CIRS scores, the BMI was not associated with 1-year mortality. The association of a high BMI with survival is observed over a longer time period than the association between CIRS scores and mortality.
Many studies have shown an inverse association between mortality and the BMI in older communitydwelling populations and in nursing home residents. However, most of these have actually shown an increased mortality in patients with a low BMI (typically <20 kg/m 2 ), with no or an only modest survival advantage associated with a high BMI (typically >27-30 kg/m 2 ) (3,20-24). Thinggaard and colleagues showed in a large cohort aged 70-95 years a trend to a decreasing association between mortality and high BMI with advancing age (25) . In contrast to these previous studies, the researchers' report focuses on older hospitalized patients with a very high prevalence of comorbidities and/or malnutrition, as evidenced by the high CIRS scores and the low MNA scores, and the high prevalence of vascular comorbidities, anemia, and hypoalbuminemia. The researchers observed no differences in survival among the three lower BMI categories. This result is actually in agreement with the previous observations on older inpatients from similar hospital services (10) . In a nursing home study with a 1-year follow-up Kaiser and colleagues found the lowest .091 CIRS (score units) .142
Notes:
For nonbinary variables, the hazard ratio (HR) corresponds to the change per unit. Bold entries = statistically significant. BMI = body mass index; MNA = Mini Nutritional Assessment; CIRS = Cumulative
Illness Rating scale-Geriatrics; GFR = glomerular filtration rates. mortality in the obese group (26) . The absence of excess mortality in patients with a BMI less than 20 kg/m 2 may be due to the strong impact of comorbidities (not necessarily associated with weight loss) on mortality also in the higher BMI categories. In simple words, the impact of comorbidities overshadows the impact of low body weight or weight loss. However, this explanation does not account for the survival advantage of patients with a high BMI. An "obesity paradox," defined by better survival in "obese" patients (BMI > 30 kg/m 2 ) than in "normal" (20-24.9 kg/ m 2 ) or even "overweight" (BMI 25-29.9 kg/m 2 ) patients, has been reported in congestive heart failure, coronary heart disease, or chronic renal insufficiency (6, (27) (28) (29) (30) . The obesity paradox observed in the study strikingly resembles the one seen in younger patients with severe disease(s), and seems distinct from the association of a low BMI with mortality in community-dwelling older subjects.
The mechanisms underlying this obesity paradox remain incompletely understood. Smoking could be involved by favoring both weight loss and mortality, but the observations were unaffected by adjustment for smoking. Because of better survival in women, the obesity paradox could be explained by a shift in the gender ratio across BMI categories. However, it was confirmed when the analysis was restricted to women. The negative impact of obesity in younger adults is in part mediated by dyslipidemia and hypertension. The association between obesity and these risk factors progressively weakens with age (31) . This explanation may account for a weak or absent, but not for an inverse association between obesity and mortality. Another proposal is that the adipose tissue mass remains associated with mortality or cardiovascular disease, but is no longer appropriately reflected by the BMI (32) . Yet, it is hard to imagine an inverse association between BMI and adipose tissue mass that would account for the obesity paradox. Unintentional weight loss has been associated with longterm mortality in numerous studies (8, 33, 34) . The obesity paradox could thus be explained by the effect of diseaserelated weight loss on both the BMI and mortality. In the context of the study, the group with the highest BMI would be the one where significant weight loss is least likely to have occurred. Disease-related weight loss most probably accounts for the higher prevalence of malignancies in the lower BMI categories. However, many other comorbidities such as diabetes, hypertension, and heart failure were more frequent in the higher BMI categories, and the overall prevalence of comorbidities was similar or even higher in the higher BMI categories. Thus, better survival in patients with a high BMI is not accounted for by a lower disease load. The distinct effect of weight loss and comorbidities is also indirectly supported by the observation that weight gain is associated with better survival in patients with cardiovascular disease (34) . Indeed, this "mirror image" observation can hardly be explained by recovery from disease. Finally, the researchers have to consider the possibility that obesity is a protective factor against mortality from acute diseases or comorbidities in the short term, even though it is an atherogenic risk factor in the long term. A higher adipose tissue or muscle mass may constitute a "nutritional reserve" when facing disease and/or malnutrition (6) .
The strengths of this study are the random patient selection procedure, the extensive characterization of comorbidities, and complete long-term mortality follow-up. The researchers' study has several limitations: body composition is missing for this cohort. The protective effect of higher BMI level might not be explained by an increased amount of adipose tissue, but rather by a higher level of lean mass (24) . Several comorbidities were assessed retrospectively by chart review, leading to possible patient misclassification with respect to individual comorbidities. For instance the diagnosis of heart failure was not confirmed by echocardiography. However, these inaccuracies are unlikely to affect the conclusions, as they would be expected to affect the assessment of all patients, irrespective of their BMI category. In addition, functional and cognitive assessments were not included in these analyses. A previous article on the same cohort, which analyzed the etiology and severity levels of cognitive status, showed that dementia was not predictive of short or long term mortality (35) . The role of renal function impairment remains uncertain, as the estimations of the GFR based on serum creatinine are biased by age, gender, and body weight and height. In the analysis a higher BMI was associated with a lower GFR calculated by the 4-parameter Modification of Diet in Renal Disease formula, and a higher GFR calculated by the Cockcroft-Gault formula. The latter was used in the mortality analysis, to favor the hypothesis that comorbidities account for the obesity paradox.
Irrespective of the underlying mechanisms, the researchers' observations have several practical implications. The obesity paradox may not be limited to mortality. Indeed, recent studies have suggested that in high-risk older persons obesity is associated with a lower prevalence of functional disabilities (26) . It follows that the screening for obesity (at least as defined by a BMI ≥ 30 kg/m 2 ) in hospitals or in nursing homes (36) is unlikely to identify high-risk populations, whether in terms of survival or functional capacities. Similarly, the inclusion of obesity in comorbidity scales such as the CIRS is unlikely to contribute to their performance as prognostic tools (19) . The absence of survival difference between patients from the three lower BMI categories also has important implications. The researchers have previously shown that malnutrition, as diagnosed by the MNA, fails to predict mortality in old hospitalized patients (11) . The MNA and other malnutrition diagnostic tools include a low BMI as an essential criterion. The present data suggest that the inability of these tools to predict survival is related to the lack of survival difference between the lower BMI categories. In older hospitalized patients, the high prevalence of comorbidities may put all patients with a BMI less than 27-30 kg/ m 2 at the same high risk of all-cause death. 
